Floatz logo

BAY 59-7939

Prevention & Control

BayerPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Prevention & Control cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Bayer
Phase 3BB
Rivaroxaban
Bayer
Phase 3BB
PANTOPRAZOLE
Bayer
Phase 3B
Epigallocatechin-3-Gallate
Shandong Cancer Hospital and Institute
Phase 2CCC

Same molecule, other indications

BAY 59-7939 is also rated in:

atrial fibrillationDormant
BB
Indicative ·
66 / 100
View asset →
stroke disorderDormant
CCC
Indicative ·
52 / 100
View asset →
venous thromboembolismDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →